Lapin v. Goldman Sachs Group, Inc.

506 F. Supp. 2d 221, 2006 U.S. Dist. LEXIS 71417, 2006 WL 2850226
CourtDistrict Court, S.D. New York
DecidedSeptember 29, 2006
Docket04CV2236 (KMK)
StatusPublished
Cited by61 cases

This text of 506 F. Supp. 2d 221 (Lapin v. Goldman Sachs Group, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lapin v. Goldman Sachs Group, Inc., 506 F. Supp. 2d 221, 2006 U.S. Dist. LEXIS 71417, 2006 WL 2850226 (S.D.N.Y. 2006).

Opinion

OPINION & ORDER

KARAS, District Judge.

This case stems from a financial securities firm’s alleged conflicts of interest. The conflict alleged pitted the firm’s securities analysts against the firm’s actual or potential investment banking clients. It is alleged that this conflict of interest, which was not disclosed by the firm to its shareholders, artificially inflated the price of the firm’s stock purchased during the relevant time period.

Lead Plaintiff, Harvey Lapin, filed this putative class action on behalf of himself and other similarly situated individuals who purchased shares of the defendant securities firm, Goldman Sachs Group, Inc. (“GS Group”), from July 1, 1999 to May 7, 2002 (the “Class Period”), a period in which the firm allegedly “employ[ed these] undisclosed improper business practices.” (Second Am. Compl. ¶ 1) (“SAC”) Plaintiff brings this action pursuant to section 10(b) of the Securities Exchange Act of 1934, 15 U.S.C. § 78j(b), and Rule 10b-5, 17 C.F.R. § 240.10b-5, promulgated thereunder. Specifically, Plaintiff alleges that the GS Group, and its subsidiary, Goldman, Sachs & Co. (collectively “Goldman”), along with GS Group’s then-Chairman and Chief Executive Officer, Henry M. Paulson (“Paulson”), violated section 10(b) and Rule 10b~5 when they misrepresented Goldman’s research analysts as “independent” and unbiased, and failed to disclose analysts’ conflicts of interest with Goldman’s investment banking clients, thereby artificially inflating the stock price of GS Group.

Defendants GS Group, Goldman and Paulson (collectively “Defendants”) move to dismiss the Complaint pursuant to Fed. R.Civ.P. 12(b)(6). For the reasons stated herein, Defendants’ Motion to Dismiss the Complaint is granted in part and denied in part.

I. Facts

A. Plaintiff’s Allegations

Except as otherwise noted, the following facts alleged in the Second Amended Complaint are presumed true for purposes of this motion. 1 Plaintiff purchased *229 shares of GS Group common stock during the Class Period, see (SAC ¶ 16), and alleges that, unbeknownst to him and other individuals who purchased GS Group stock during the Class Period, Defendants “engaged in a series of undisclosed acts and practices that created conflicts of interest for [their] research analysts with respect to investment banking considerations.” (SAC ¶ 26) These practices were allegedly used to help Goldman compete for Initial Public Offering (“IPO”) business, which “resulted in lucrative banking fees and the promise of future investment banking and related businesses such as fees from secondary offerings, making bridge loans and other corporate financing transactions, and advising on mergers and acquisitions.” (SAC ¶ 25) To accomplish that goal, Goldman, “among other things, compensated its research analysts in large part based on the degree to which they helped generate investment banking business for Goldman Sachs, offered its research coverage as a marketing tool to gain investment banking business, and failed to establish adequate procedures to protect research analysts from conflicts of interest.” (SAC ¶ 26)

During the Class Period, Defendants allegedly made false and misleading statements to hide these practices and their potentially fraudulent nature. (See generally SAC ¶¶ 119-34) These statements can be grouped into four categories. The first category consists of statements, including ratings of publicly traded stocks, that describe Goldman’s stock research as high quality, unbiased research, which relies on objective criteria (e.g., “[u]nder [new] leadership, we will maximize our standing in the U.S. investment community and strengthen our reputation for providing insightful, unbiased research,” SAC ¶ 130). {See SAC ¶¶ 119-20, 128, 130-31) The second category consists of statements trumpeting Goldman analysts who have received high rankings in industry polls, and awards that Goldman analysts had received (e.g., “[o]ur Research Department is the only one to rank in the top three in each of the last 15 calendar years in Institutional Investor’s ‘All-America Research Team’ survey,” SAC ¶ 125). {See SAC ¶¶ 125, 127). The third category consists of statements noting Goldman’s high ethical standards and its compliance with industry rules and regulations (e.g., “[w]e are dedicated to complying fully with the letter and spirit of the laws, rules and ethical principles that govern us,” SAC ¶ 124). {See SAC ¶ 124) The fourth and final category involves omissions, rather than affirmative statements, in which Goldman “failed to give an indication of the great extent to which individual conflicts of interest were biasing analyst opinions” in equity research reports. (SAC ¶ 122)

Plaintiff alleges that all of these statements violated securities law, because “they failed to disclose that during the Class Period defendants were engaged in a series of undisclosed and improper business practices pursuant to which Goldman Sachs failed to issue quality, objective, unbiased research reports concerning the common stocks of the companies for which Goldman Sachs provided or sought to provide investment banking services.” (SAC ¶¶ 121, 123, 126, 129, 133) These practices allegedly included:

compensating research analysts primarily based on the degree to which they helped generate investment banking *230 business, offering companies research coverage by its analysts as a marketing tool to gain investment banking business, initiating or terminating research coverage and rating stocks based on investment banking business rather than an opinion of the company’s prospects and business following expert research and analysis, and a general failure to establish adequate procedures to protect research analysts from conflicts of interests.

(SAC ¶¶ 121, 123, 126, 129, 133) Plaintiff also alleges that these statements were false in light of Goldman’s failure to abide by then-applicable NYSE and NASD regulations, (see SAC ¶ 91-103) and its failure to adequately supervise its analysts, (see SAC ¶¶ 89-90) including the implementation and oversight over a so-called “Chinese Wall” that was “required to prevent the conflicts of interest that could obviously result when a firm analyzes and recommends the very securities it has itself issued or underwritten.” Shah v. Meeker, 435 F.3d 244, 247 (2d Cir.2006)

The Second Amended Complaint alleges that Goldman’s statements lauding its analysts and their reports as unbiased and objective ran counter to its internal pronouncements. For example, in “pitch-books” used to recruit potential new investment banking clients, Goldman marketed its research coverage to suggest that Goldman’s supposed objective coverage would be rose-tinted once Goldman concluded the banking transaction.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
506 F. Supp. 2d 221, 2006 U.S. Dist. LEXIS 71417, 2006 WL 2850226, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lapin-v-goldman-sachs-group-inc-nysd-2006.